SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval. The company unveiled the device — which it touts as the world’s thinnest CGM — at last week’s 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Amsterdam. GS3 features an ultra-compact design and […]
ATTD 2025
The biggest diabetes tech news out of ATTD 2025
Last week, Amsterdam played host to this year’s edition of the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). For the 18th edition of this event, some of the biggest names in diabetes technology put their latest innovations on display. Updates for insulin delivery and glucose monitoring technologies dominated the headlines as many […]
Why Dexcom is making a push to bring CGM to more people with type 2 diabetes
Of the hundreds of millions of people living with diabetes, the vast majority live with type 2. Dexcom (Nasdaq:DXCM) wants to make sure they have the tools to manage that. The International Diabetes Federation says that more than 90% of people with diabetes have type 2 diabetes. Yet, that population remains significantly under-penetrated by the […]
Medtronic reports first real-world data on smart insulin pen system
Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination. The data evaluated Medtronic’s Smart MDI system, which combines the InPen with the Simplera continuous glucose monitor (CGM). Data showed how the system, designed for people with diabetes using multiple daily injections (MDI) when used as intended, […]
Insulet study shows improvements with Omnipod 5 transitioning from multiple daily injections
Insulet (Nasdaq:PODD) today announced new Omnipod 5 clinical data highlighting the transition from multiple daily injections (MDI). Investigators shared data from the RADIANT study at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Amsterdam. The randomized controlled trial evaluated the direct transition from MDI to automated insulin delivery (AID). Insulet […]
Tandem has positive data for automated insulin delivery in type 2 diabetes population
Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for type 2 diabetes. San Diego-based Tandem won FDA clearance for its Control-IQ+ next-generation algorithm for type 2 diabetes at the end of last month. Just yesterday, the company announced the launch of the algorithm. Control-IQ+ represents the next generation of the […]
Dexcom CGM now connects with Novo Nordisk smart insulin pens, 15-day CGM shows promise
![The NovoPen Echo smart insulin pen now works with Dexcom CGM. [Image from Novo Nordisk]](https://www.drugdeliverybusiness.com/wp-content/uploads/2022/11/Novo-Nordisk-NovoPen-Echo-Smart-Insulin-Pen-Abbott-150x86.jpg)
Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors (CGMs). The company shared its updates at the 18th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) in Amsterdam. It also revealed new findings about attitudes toward the use of technology in the type 2 diabetes population. Today, […]
Dexcom study finds that providers prefer tech over medication for type 2 diabetes
Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments. The “Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East” surveyed 2,500 people. It featured individuals with type 2 diabetes and healthcare professionals across Germany, Italy, the Netherlands, Saudi Arabia, Spain and the […]
